These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34744979)

  • 21. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.
    ; Obeso JA; Olanow CW; Rodriguez-Oroz MC; Krack P; Kumar R; Lang AE
    N Engl J Med; 2001 Sep; 345(13):956-63. PubMed ID: 11575287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
    Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
    Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of Advanced Parkinson's Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience.
    Rabie A; Verhagen Metman L; Fakhry M; Eassa AY; Fouad W; Shakal A; Slavin KV
    Brain Sci; 2016 Dec; 6(4):. PubMed ID: 27983589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease.
    Li K; Haase R; Rüdiger H; Reimann M; Reichmann H; Wolz M; Ziemssen T
    Sci Rep; 2017 Aug; 7(1):7012. PubMed ID: 28765629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.
    Guo X; Gao G; Wang X; Li L; Li W; Liang Q; Zhang H
    Stereotact Funct Neurosurg; 2008; 86(4):237-44. PubMed ID: 18477840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of subthalamic deep brain stimulation on bradykinesia of proximal and distal upper limb muscles in Parkinson's disease.
    Dafotakis M; Fink GR; Allert N; Nowak DA
    J Neurol; 2008 Mar; 255(3):429-37. PubMed ID: 18343967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not.
    Shivitz N; Koop MM; Fahimi J; Heit G; Bronte-Stewart HM
    Mov Disord; 2006 Aug; 21(8):1088-97. PubMed ID: 16671073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study.
    Artusi CA; Bortolani S; Merola A; Zibetti M; Busso M; De Mercanti S; Arnoffi P; Martinetto S; Gaidolfi E; Veltri A; Barbero P; Lopiano L
    Parkinsonism Relat Disord; 2019 May; 62():231-235. PubMed ID: 30442481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Effects of Subthalamic Deep Brain Stimulation on Motor Outcomes in Parkinson's Disease; 13 Year Follow Up.
    Zhou H; Wang L; Zhang C; Qiu X; Hu W; van der Stelt O; Ramirez-Zamora A; Li D
    Front Neurol; 2019; 10():689. PubMed ID: 31293511
    [No Abstract]   [Full Text] [Related]  

  • 34. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
    Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
    J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost analysis of intraoperative microelectrode recording during subthalamic stimulation for Parkinson's disease.
    McClelland S
    Mov Disord; 2011 Jul; 26(8):1422-7. PubMed ID: 21674622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sign-specific stimulation 'hot' and 'cold' spots in Parkinson's disease validated with machine learning.
    Boutet A; Germann J; Gwun D; Loh A; Elias GJB; Neudorfer C; Paff M; Horn A; Kuhn AA; Munhoz RP; Kalia SK; Hodaie M; Kucharczyk W; Fasano A; Lozano AM
    Brain Commun; 2021; 3(2):fcab027. PubMed ID: 33870190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved asymmetry of gait in Parkinson's disease with DBS: gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus.
    Johnsen EL; Mogensen PH; Sunde NA; Østergaard K
    Mov Disord; 2009 Mar; 24(4):590-7. PubMed ID: 19097189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson's disease.
    Sürücü O; Baumann-Vogel H; Uhl M; Imbach LL; Baumann CR
    Pain; 2013 Aug; 154(8):1477-9. PubMed ID: 23632230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.